BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25299056)

  • 1. QM/MM molecular dynamics study of the galactopyranose → galactofuranose reaction catalysed by Trypanosoma cruzi UDP-galactopyranose mutase.
    Pierdominici-Sottile G; Cossio Pérez R; Galindo JF; Palma J
    PLoS One; 2014; 9(10):e109559. PubMed ID: 25299056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical mechanism of UDP-galactopyranose mutase from Trypanosoma cruzi: a potential drug target against Chagas' disease.
    Oppenheimer M; Valenciano AL; Kizjakina K; Qi J; Sobrado P
    PLoS One; 2012; 7(3):e32918. PubMed ID: 22448231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Dynamics Simulations of Substrate Release from Trypanosoma cruzi UDP-Galactopyranose Mutase.
    Cossio-Pérez R; Pierdominici-Sottile G; Sobrado P; Palma J
    J Chem Inf Model; 2019 Feb; 59(2):809-817. PubMed ID: 30608160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate-dependent dynamics of UDP-galactopyranose mutase: Implications for drug design.
    Boechi L; de Oliveira CA; Da Fonseca I; Kizjakina K; Sobrado P; Tanner JJ; McCammon JA
    Protein Sci; 2013 Nov; 22(11):1490-501. PubMed ID: 23934860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of unique active site residues of eukaryotic UDP-galactopyranose mutases to substrate recognition and active site dynamics.
    Da Fonseca I; Qureshi IA; Mehra-Chaudhary R; Kizjakina K; Tanner JJ; Sobrado P
    Biochemistry; 2014 Dec; 53(49):7794-804. PubMed ID: 25412209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steric Control of the Rate-Limiting Step of UDP-Galactopyranose Mutase.
    Pierdominici-Sottile G; Cossio-Pérez R; Da Fonseca I; Kizjakina K; Tanner JJ; Sobrado P
    Biochemistry; 2018 Jul; 57(26):3713-3721. PubMed ID: 29757624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of Trypanosoma cruzi UDP-galactopyranose mutase implicate flexibility of the histidine loop in enzyme activation.
    Dhatwalia R; Singh H; Oppenheimer M; Sobrado P; Tanner JJ
    Biochemistry; 2012 Jun; 51(24):4968-79. PubMed ID: 22646091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and partial characterization of two eukaryotic UDP-galactopyranose mutases.
    Bakker H; Kleczka B; Gerardy-Schahn R; Routier FH
    Biol Chem; 2005 Jul; 386(7):657-61. PubMed ID: 16207086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, mechanism, and dynamics of UDP-galactopyranose mutase.
    Tanner JJ; Boechi L; Andrew McCammon J; Sobrado P
    Arch Biochem Biophys; 2014 Feb; 544():128-41. PubMed ID: 24096172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel inhibitors against UDP-galactopyranose mutase to combat leishmaniasis.
    Kashif M; Tabrez S; Husein A; Arish M; Kalaiarasan P; Manna PP; Subbarao N; Akhter Y; Rub A
    J Cell Biochem; 2018 Mar; 119(3):2653-2665. PubMed ID: 29058760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and analysis of substrate analogues for UDP-galactopyranose mutase: implication for an oxocarbenium ion intermediate in the catalytic mechanism.
    Itoh K; Huang Z; Liu HW
    Org Lett; 2007 Mar; 9(5):879-82. PubMed ID: 17266324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP.
    Partha SK; van Straaten KE; Sanders DA
    J Mol Biol; 2009 Dec; 394(5):864-77. PubMed ID: 19836401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,4-Anhydrogalactopyranose is not an intermediate of the mutase catalyzed UDP-galactopyranose/furanose interconversion.
    Caravano A; Sinaÿ P; Vincent SP
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1123-5. PubMed ID: 16377186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tautomerization in the UDP-galactopyranose mutase mechanism: a DFT-cluster and QM/MM investigation.
    Huang W; Gauld JW
    J Phys Chem B; 2012 Dec; 116(48):14040-50. PubMed ID: 23148701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insight into the unique substrate binding mechanism and flavin redox state of UDP-galactopyranose mutase from Aspergillus fumigatus.
    van Straaten KE; Routier FH; Sanders DA
    J Biol Chem; 2012 Mar; 287(14):10780-90. PubMed ID: 22334662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate directs enzyme dynamics by bridging distal sites: UDP-galactopyranose mutase.
    Yao X; Bleile DW; Yuan Y; Chao J; Sarathy KP; Sanders DA; Pinto BM; O'Neill MA
    Proteins; 2009 Mar; 74(4):972-9. PubMed ID: 18767162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Crystallo Capture of a Covalent Intermediate in the UDP-Galactopyranose Mutase Reaction.
    Mehra-Chaudhary R; Dai Y; Sobrado P; Tanner JJ
    Biochemistry; 2016 Feb; 55(6):833-6. PubMed ID: 26836146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutagenesis of UDP-galactopyranose mutase reveals a critical role for the active-site, conserved arginine residues.
    Chad JM; Sarathy KP; Gruber TD; Addala E; Kiessling LL; Sanders DA
    Biochemistry; 2007 Jun; 46(23):6723-32. PubMed ID: 17511471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UDP-Galp mutase catalyzed isomerization: synthesis and evaluation of 1,4-anhydro-beta-D-galactopyranose and its [2.2.2] methylene homologue.
    Sadeghi-Khomami A; Forcada TJ; Wilson C; Sanders DA; Thomas NR
    Org Biomol Chem; 2010 Apr; 8(7):1596-602. PubMed ID: 20237670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and inhibition properties of conformational probes for the mutase-catalyzed UDP-galactopyranose/furanose interconversion.
    Caravano A; Mengin-Lecreulx D; Brondello JM; Vincent SP; Sinaÿ P
    Chemistry; 2003 Dec; 9(23):5888-98. PubMed ID: 14673861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.